The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis

por Provan, Sella A, Dean, Linda E, Jones, Gareth T, Macfarlane, Gary J
Publicado 2021

Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during bi...

por Hammer, Hilde Berner, Michelsen, Brigitte, Sexton, Joe, Uhlig, Till, Provan, Sella A.
Publicado 2020

The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study

por Provan, Sella A, Angel, Kristin, Ødegård, Sigrid, Mowinckel, Petter, Atar, Dan, Kvien, Tore K
Publicado 2008

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study

por Christensen, Ingrid Egeland, Lillegraven, Siri, Mielnik, Pawel, Bakland, Gunnstein, Loli, Liz, Sexton, Joe, Uhlig, Till, Kvien, Tore K, Provan, Sella A
Publicado 2022

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

por Delcoigne, Benedicte, Ljung, Lotta, Provan, Sella A, Glintborg, Bente, Hetland, Merete Lund, Grøn, Kathrine Lederballe, Peltomaa, Ritva, Relas, Heikki, Turesson, Carl, Gudbjornsson, Bjorn, Michelsen, Brigitte, Askling, Johan
Publicado 2022

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis

por Provan, S. A., Rollefstad, S., Ikdahl, E., Mathiessen, A., Berg, I. J., Eeg, I., Wilkinson, I. B., McEniery, C. M., Kvien, T. K., Hammer, H. B., Østerås, N., Haugen, I. K., Semb, A. G.
Publicado 2019

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

por Glintborg, Bente, Di Giuseppe, Daniela, Wallman, Johan K, Provan, Sella A, Nordström, Dan, Hokkanen, Anna-Mari, Österlund, Jenny, Kristianslund, Eirik, Kvien, Tore K, Gudbjornsson, Bjorn , Hetland, Merete Lund, Michelsen, Brigitte, Jacobsson, Lennart, Askling, Johan , Lindström, Ulf
Publicado 2022

Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis

por Maehlen, Marthe T., Provan, Sella A., de Rooy, Diederik P. C., van der Helm - van Mil, Annette H. M., Krabben, Annemarie, Saxne, Tore, Lindqvist, Elisabet, Semb, Anne Grete, Uhlig, Till, van der Heijde, Désirée, Mero, Inger Lise, Olsen, Inge C., Kvien, Tore K., Lie, Benedicte A.
Publicado 2013

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

por Chatzidionysiou, Katerina, Hetland, Merete Lund, Frisell, Thomas, Di Giuseppe, Daniela, Hellgren, Karin, Glintborg, Bente, Nordström, Dan, Aaltonen, Kalle, Törmänen, Minna RK, Klami Kristianslund, Eirik, Kvien, Tore K, Provan, Sella A, Guðbjörnsson, Bjorn, Dreyer, Lene, Kristensen, Lars Erik, Jørgensen, Tanja Schjødt, Jacobsson, Lennart, Askling, Johan
Publicado 2018

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

por Bjørlykke, Kristin H, Ørbo, Hilde S, Tveter, Anne T, Jyssum, Ingrid, Sexton, Joseph, Tran, Trung T, Christensen, Ingrid E, Kro, Grete Birkeland, Kvien, Tore K, Jahnsen, Jørgen, Munthe, Ludvig A, Chopra, Adity, Warren, David J, Mjaaland, Siri, Haavardsholm, Espen A, Grødeland, Gunnveig, Provan, Sella A, Vaage, John T, Syversen, Silje Watterdal, Goll, Guro Løvik, Jørgensen, Kristin Kaasen
Publicado 2023

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy

por Syversen, Silje W., Jyssum, Ingrid, Tveter, Anne T., Tran, Trung T., Sexton, Joseph, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Grødeland, Gunnveig, Nissen‐Meyer, Lise S. H., Ricanek, Petr, Chopra, Adity, Andersson, Ane M., Kro, Grete B., Jahnsen, Jørgen, Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T., Lund‐Johansen, Fridtjof, Jørgensen, Kristin K., Goll, Guro L.
Publicado 2022

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study

por Jyssum, Ingrid, Kared, Hassen, Tran, Trung T, Tveter, Anne T, Provan, Sella A, Sexton, Joseph, Jørgensen, Kristin K, Jahnsen, Jørgen, Kro, Grete B, Warren, David J, Vaage, Eline B, Kvien, Tore K, Nissen-Meyer, Lise-Sofie H, Anderson, Ane Marie, Grødeland, Gunnveig, Haavardsholm, Espen A, Vaage, John Torgils, Mjaaland, Siri, Syversen, Silje Watterdal, Lund-Johansen, Fridtjof, Munthe, Ludvig A, Goll, Guro Løvik
Publicado 2022

Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY

por Joergensen, Kristin K., Syversen, Silje W, Jyssum, ingrid, Tveter, Anne Therese, Tran, Trung T., Sexton, Joe, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Gr⊘deland, Gunnveig, Nissen-Meyer, Lise Sofie H., Ricanek, Petr, Chopra, Adity, Anderson, Ane M., Kro, Grete B., Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T.T., Lund-Johansen, Fridtjof, Jahnsen, Jorgen, Goll, Guro L.
Publicado 2022